<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25375" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Mural Thrombi</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Davinder P.</given-names>
          </name>
          <aff>Shrimann Superspecialty Hospital, Jalandhar, Punjab</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Basit</surname>
            <given-names>Hajira</given-names>
          </name>
          <aff>Brookdale University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malik</surname>
            <given-names>Ahmad</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahajan</surname>
            <given-names>Kunal</given-names>
          </name>
          <aff>Holy Heart Advanced Cardiac Care Centre</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Davinder Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Hajira Basit declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ahmad Malik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kunal Mahajan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25375.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Mural thrombi are thrombi that attach to the wall of a blood vessel and cardiac chamber. Mural thrombus occurrence in a normal or minimally atherosclerotic vessel is a rare entity in the absence of a hypercoagulative state or inflammatory, infectious, or familial aortic ailments. Mural thrombi can be seen in large vessels such as the heart and aorta and can restrict blood flow. They are mostly located in the descending aorta, and less commonly, in the aortic arch or the abdominal aorta. This activity reviews the cause, pathophysiology, presentation, and diagnosis of mural thrombi and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of mural thrombus.</p></list-item><list-item><p>Review the evaluation of a patient with mural thrombus.</p></list-item><list-item><p>Outline the management options available for mural thrombus.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and outcomes in patients with mural thrombus.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25375&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25375">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25375.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Mural thrombi are thrombi that attach to the wall of a blood vessel and cardiac chamber. Mural thrombus occurrence in a normal or minimally atherosclerotic vessel is a rare&#x000a0;entity&#x000a0;in the absence of&#x000a0;a hypercoagulative&#x000a0;state or inflammatory, infectious, or familial aortic ailments.&#x000a0;Mural thrombi&#x000a0;can be seen&#x000a0;in large vessels such as the heart and aorta and can restrict blood flow.&#x000a0;They are mostly located in the descending aorta, and less commonly, in the aortic arch or the abdominal aorta. Mural thrombi can invade any cardiac chamber. Left ventricular thrombus is a frequent complication of acute myocardial infarction, mostly with the involvement of the cardiac apex. This thrombus can separate from&#x000a0;the ventricle and travel through arteries, blocking any blood vessels.<xref ref-type="bibr" rid="article-25375.r1">[1]</xref></p>
      </sec>
      <sec id="article-25375.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Virchow triad describes the pathogenesis of thrombus formation. Endothelial injury&#x000a0;initiates&#x000a0;the process.&#x000a0;It is induced by trauma&#x000a0;to the endothelium of blood vessels. Abnormal laminar flow&#x000a0;induced by turbulence in arteries propagates the process. Valvulitis or an aneurysm induces it. Then hypercoagulability further enhances the thrombosis. Leukemia or coagulation disorders induce hypercoagulability. These three factors create a cascade of events leading to the propagation of thrombus that ultimately occludes the vessels and produces complications.<xref ref-type="bibr" rid="article-25375.r2">[2]</xref></p>
      </sec>
      <sec id="article-25375.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Before the lytic and urgent interventional era, left ventricular thrombus occurred in 25% to 40% of patients after a first&#x000a0;anteroapical&#x000a0;myocardial infarction. With&#x000a0;the advent of&#x000a0;acute reperfusion strategies, there has been a decline in prevalence. The major risk of left ventricular thrombus is subsequent embolization with&#x000a0;stroke&#x000a0;or major organ loss. Historically, the likelihood of embolic events was greatest in the first two weeks after the acute event and tapered off over the ensuing six weeks. After this time, there&#x000a0;was presumed&#x000a0;endothelization&#x000a0;of the thrombus with&#x000a0;a reduction in its embolic potential. Now, with the use of thrombolytics and anticoagulants, the incidence of thrombi has diminished but not to a great extent.</p>
      </sec>
      <sec id="article-25375.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Thrombus formation starts&#x000a0;in response to injury, activating the hemostatic process. Platelets are activated by exposure to collagen or tissue factor. This causes a further cascade of platelet activation with the release of cytokines, ultimately causing thrombus formation. A number of cardiac conditions pose an increased risk of thrombus formation. These include atrial fibrillation, heart valve replacement, deep venous thrombosis, acute myocardial infarction, and genetic coagulation disorder. The whole process is regulated by thermoregulation. Large thrombus in a vessel can occlude a vessel and can induce ischemia, also termed as mural thrombi, resulting in the death of tissue. Sometimes thrombi are free-floating and can dislodge to the distal vessel. Embolization to the brain can lead to stroke. Embolization to the limb can lead to amputation.</p>
      </sec>
      <sec id="article-25375.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>They appear reddish-gray, representing bands of fibrin with entrapped white blood cells (WBC) and red blood cells (RBC).&#x000a0;Thrombi are classified&#x000a0;into 3 major groups depending on the relative amount of platelets and RBC. Three major groups are white thrombi,&#x000a0;characterized&#x000a0;by a predominance of platelets; red thrombi characterized&#x000a0;by a predominance of RBC; and mixed with features of both white and red thrombi. Thrombi may be mobile, a characteristic&#x000a0;that has been associated&#x000a0;with a higher embolic potential. On&#x000a0;occasion, fresh thrombi take on a cystic appearance. This is due to a combination of factors including varying degrees of maturity of the clot and results in acoustic boundaries between relatively fresh and more organized regions.</p>
      </sec>
      <sec id="article-25375.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The mural thrombus may be symptomatic or may be diagnosed&#x000a0;as an incidental finding. Symptoms are mainly related to the localization&#x000a0;of the thrombus. It can be&#x000a0;incidentally detected lying in walls of the aorta in an asymptomatic&#x000a0;patient. Its&#x000a0;embolization to the brain induces cerebrovascular events, causes mesenteric ischemia in the gut, and causes renal&#x000a0;infarction, coronary ischemia in the heart, pulmonary infarction, among others.&#x000a0;Its&#x000a0;presence&#x000a0;in the distal part of the vessel&#x000a0;can induce ischemia, which can&#x000a0;result in&#x000a0;limb loss.<xref ref-type="bibr" rid="article-25375.r3">[3]</xref></p>
      </sec>
      <sec id="article-25375.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Various modalities can help in a diagnosis, but the modality of choice for the diagnosis of mural thrombi is CT or MRI angiography. These tools are best for determining the location and extent of mural thrombi. These modalities are costly but helpful in the prognostication of disease.<xref ref-type="bibr" rid="article-25375.r4">[4]</xref>&#x000a0;Transoesophageal echocardiography (TEE) is another, relatively noninvasive option and&#x000a0;a good&#x000a0;tool for diagnosis.&#x000a0;TTE&#x000a0;&#x000a0;is an inexpensive, bedside procedure with&#x000a0;a low&#x000a0;risk of complications.&#x000a0;TEE is also helpful in diagnosing left ventricle thrombus and aortic atheroma especially&#x000a0;in ascending aorta. Both MRI and CT are more sensitive than TEE in detecting the thrombus in an entire thoracic aorta. Both&#x000a0;are usually well tolerated. Other modalities like intravascular ultrasound or optical coherence tomography have opened up&#x000a0;a new&#x000a0;era of defining thrombi.</p>
      </sec>
      <sec id="article-25375.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of thrombi could&#x000a0;reduce&#x000a0;the risk of stroke, myocardial infarction, and pulmonary embolism. There are no standardized&#x000a0;guidelines&#x000a0;for the treatment of mural thrombi.&#x000a0;Heparin and warfarin are often used&#x000a0;to inhibit the initiation and&#x000a0;propagation&#x000a0;of existing thrombi.&#x000a0;Heparin binds to and activates the enzyme inhibitor antithrombin 3, and warfarin inhibits vitamin K epoxide reductase, both enzymes are needed to produce clotting factors. Heparin&#x000a0;is a preferred&#x000a0;drug&#x000a0;for dissolving&#x000a0;the clot. If thrombi do not resolve&#x000a0;after two weeks of heparin therapy, then surgery is an option. Thrombolytic therapy is another option for&#x000a0;clot&#x000a0;dissolution. It includes streptokinase, urokinase,&#x000a0;reteplase, and tenecteplase. These&#x000a0;are usually administered&#x000a0;intravenously.&#x000a0;Surgical candidates include younger&#x000a0;patients, those having a low risk of perioperative complications, those in whom conservative treatment is unsuccessful, and those who have a highly mobile thrombus with high embolic risk. The surgical procedure&#x000a0;includes thrombectomy, segmental aortic resection,&#x000a0;thromboaspiration, and endoluminal&#x000a0;stent-grafts. No approach is definitively&#x000a0;superior.&#x000a0;Endoluminal&#x000a0;stent grafting is the least invasive option, but it carries a high risk of distal embolization through wire manipulation and stent deployment.<xref ref-type="bibr" rid="article-25375.r5">[5]</xref><xref ref-type="bibr" rid="article-25375.r6">[6]</xref><xref ref-type="bibr" rid="article-25375.r7">[7]</xref><xref ref-type="bibr" rid="article-25375.r8">[8]</xref></p>
      </sec>
      <sec id="article-25375.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Mural thrombi in the cardiac cavity can mimic a cardiac mass. In the aortic wall, it can appear as mural hematoma or aortic dissection.</p>
      </sec>
      <sec id="article-25375.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>If left untreated the patients are at risk of embolization leading to a cerebrovascular infarction as the most feared complication. In general, with appropriate therapy, the prognosis related to mural thrombi is favorable.</p>
      </sec>
      <sec id="article-25375.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Left ventricular thrombi can embolize to the brain or any other body organ causing fatal events. Aortic mural thrombi have high chances of embolization and a higher incidence of limb loss. Mesenteric ischemia, renal infarction, vision loss, myocardial infarction are other rare complications.</p>
      </sec>
      <sec id="article-25375.s13" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Anticoagulation is an effective means of controlling and preventing the further progression of mural thrombi.</p>
      </sec>
      <sec id="article-25375.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The occurrence of mural thrombi has detrimental effects on the morbidity and mortality of cardiac patients. Earlier detection and initiation of timely anticoagulation prevents many complications.</p>
      </sec>
      <sec id="article-25375.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Early detection of mural thrombi is of great importance for preventing the complication arising from embolization of thrombi.</p>
      </sec>
      <sec id="article-25375.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of mural thrombi are best done with an interprofessional team that includes an internist, cardiologist, neurologist, radiologist, vascular surgeon, and a team of specialty nurses. It is vital to treat mural thrombi as this can lower the risk of stroke, myocardial infarction, and pulmonary embolism. There are no standardized&#x000a0;guidelines&#x000a0;for the treatment of mural thrombi. The type of treatment depends on the location of thrombi, patient symptoms, and urgency of the situation. Even after treatment, patients may have to remain on some type of anticoagulation until the cause of the thrombus has been identified and treated.<xref ref-type="bibr" rid="article-25375.r9">[9]</xref><xref ref-type="bibr" rid="article-25375.r1">[1]</xref></p>
        <p>The prognosis for patients with mural thrombi is good but in the presence of emboli, the prognosis is guarded.<xref ref-type="bibr" rid="article-25375.r10">[10]</xref></p>
      </sec>
      <sec id="article-25375.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25375&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25375">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/mural-thrombi/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25375">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25375/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25375">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25375.s18">
        <title>References</title>
        <ref id="article-25375.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bianchini Massoni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Azzarone</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ucci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gallitto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Freyrie</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Significance and Risk Factors for Intraprosthetic Mural Thrombus in Abdominal Aortic Endografts: A Systematic Review and Meta-analysis.</article-title>
            <source>Ann Vasc Surg</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>53</volume>
            <fpage>234</fpage>
            <page-range>234-242</page-range>
            <pub-id pub-id-type="pmid">30012445</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eren</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gungor</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kocyigit</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Guzel</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Erken</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Altunoren</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Tatar</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Eroglu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Senel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kaya</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Payda&#x0015f;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Onan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yilmaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ulu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gursu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ozkok</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yildiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kurultak</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Ucar</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Tanrisev</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Turgutalp</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Turan</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Huzmeli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Soypacaci</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Akdam</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Huddam</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Adibelli</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Kara</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Inci</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turkmen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tekce</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Dogukan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Turkmen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Acute renal infarction in Turkey: a review of 121 cases.</article-title>
            <source>Int Urol Nephrol</source>
            <year>2018</year>
            <month>Nov</month>
            <volume>50</volume>
            <issue>11</issue>
            <fpage>2067</fpage>
            <page-range>2067-2072</page-range>
            <pub-id pub-id-type="pmid">30251011</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cicenia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fedele</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Petronilli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>De Carlo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moscucci</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Schina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sciomer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Hidden in the heart: A peculiar type of left ventricular remodeling after acute myocardial infarction.</article-title>
            <source>Echocardiography</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>1738</fpage>
            <page-range>1738-1739</page-range>
            <pub-id pub-id-type="pmid">28840949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desouza</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sood</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baciewicz</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Cardozo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Traumatic Aortic Mural Thrombus Diagnosed Echocardiographically before Thoracic Endovascular Aortic Repair.</article-title>
            <source>Tex Heart Inst J</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>3</issue>
            <fpage>188</fpage>
            <page-range>188-189</page-range>
            <pub-id pub-id-type="pmid">30072862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>DeKornfeld</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Boll</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ziegler</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Ratcliff</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Naslund</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Garrard</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Valentine</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Curci</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Initial and intermediate-term treatment of the phantom thrombus (primary non-occlusive mural thrombus on normal arteries).</article-title>
            <source>Vasc Med</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>549</fpage>
            <page-range>549-554</page-range>
            <pub-id pub-id-type="pmid">30124120</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ren</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Treatment of aortic thrombosis with retrievable stent filter and thrombolysis: a case report.</article-title>
            <source>BMC Cardiovasc Disord</source>
            <year>2019</year>
            <month>Mar</month>
            <day>05</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>54</fpage>
            <pub-id pub-id-type="pmid">30836958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>ZD</given-names>
              </name>
              <name>
                <surname>Fu</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>FF</given-names>
              </name>
            </person-group>
            <article-title>Catheter Aspiration With Recanalization for Budd-Chiari Syndrome With Inferior Vena Cava Thrombosis.</article-title>
            <source>Surg Laparosc Endosc Percutan Tech</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>304</fpage>
            <page-range>304-307</page-range>
            <pub-id pub-id-type="pmid">30629033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yagyu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Naito</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nakagawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Aortic Mural Thrombus in the Non-atherosclerotic Aorta of Patients with Multiple Hypercoagulable Factors.</article-title>
            <source>Intern Med</source>
            <year>2019</year>
            <month>Feb</month>
            <day>01</day>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>381</fpage>
            <page-range>381-385</page-range>
            <pub-id pub-id-type="pmid">30210102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Muroya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kawamoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koba</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Omura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Aortic Thrombosis in a Patient With Malignant Disease: A Literature Review and Case Presentation.</article-title>
            <source>Vasc Endovascular Surg</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>53</volume>
            <issue>2</issue>
            <fpage>139</fpage>
            <page-range>139-144</page-range>
            <pub-id pub-id-type="pmid">30466376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25375.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyermann</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Trani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Caputo</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>JV</given-names>
              </name>
            </person-group>
            <article-title>Descending thoracic aortic mural thrombus presentation and treatment strategies.</article-title>
            <source>J Vasc Surg</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>931</fpage>
            <page-range>931-936</page-range>
            <pub-id pub-id-type="pmid">28754361</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
